BH19 'JAK in the Box?' Long-Term Safety Concerns with Oral Janus Kinase Inhibitors for Alopecia Areata

    June 2025 in “ British Journal of Dermatology ”
    Talha Munir, Faisal Dubash
    Studysummary This study reviewed clinical trials on JAK inhibitors for alopecia areata, finding them effective for short-term hair regrowth with a favorable safety profile, but noted limited data on long-term risks like malignancies or cardiovascular events beyond two years.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on academic.oup.com →
    Discuss this study in the Community →